Financial Statements — NRXS
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 |
|---|
| Cash & Equivalents | 8.32 | 7.08 | 4.38 | 5.99 | 2.01 | 0.26 | 1.77 | 0.08 | 0.76 | 0.05 |
| Accounts Receivable | 0.43 | 0.39 | 0.11 | 0.13 | 0.24 | 0.05 | 0.15 | 0.09 | 0.13 | 0.24 |
| Inventory | 0.28 | 0.24 | 0.11 | 0.13 | 0.04 | 0.02 | 0.04 | 0.02 | 0.03 | 0.04 |
| Total Current Assets | 9.41 | 8.14 | 4.99 | 6.62 | 2.54 | 0.63 | 2.11 | 0.41 | 0.97 | 0.35 |
| Property, Plant & Equipment | 0.07 | 0.07 | 0.09 | 0.10 | 0.10 | 0.09 | 0.10 | 0.10 | 0.08 | 0.09 |
| Intangible Assets | 0.26 | 0.27 | 0.28 | 0.09 | 0.09 | 0.10 | 0.10 | 0.11 | 0.11 | 0.07 |
| Total Non-current Assets* | 0.58 | 0.60 | 0.79 | 0.47 | 0.49 | 0.51 | 0.52 | 0.54 | 0.27 | 1.19 |
| Total Assets | 10.00 | 8.75 | 5.78 | 7.09 | 3.03 | 1.14 | 2.63 | 0.95 | 1.24 | 1.54 |
| Accounts Payable | 0.79 | 0.31 | 0.89 | 0.46 | 0.54 | 0.96 | 1.12 | 1.24 | 0.57 | 2.44 |
| Short-term Debt | 0.04 | 0.10 | 0.20 | 0.12 | 0.08 | 0.15 | 4.77 | 1.40 | 0.19 | 1.50 |
| Total Current Liabilities | 3.10 | 2.81 | 3.15 | 2.35 | 2.10 | 2.66 | 7.59 | 3.82 | 2.26 | 11.43 |
| Total Non-current Liabilities* | 0.16 | 0.18 | 0.34 | 0.49 | 0.67 | 0.27 | 0.30 | 0.31 | 0.04 | 0.09 |
| Total Liabilities | 3.26 | 3.00 | 3.49 | 2.83 | 2.77 | 2.94 | 7.89 | 4.13 | 2.30 | 11.52 |
| Retained Earnings | (69.66) | (66.36) | (62.89) | (60.77) | (59.08) | (55.35) | (53.60) | (50.68) | (43.24) | (38.34) |
| Total Stockholder Equity | 6.74 | 5.75 | 2.28 | 4.25 | 0.26 | (1.79) | (5.26) | (3.18) | (1.06) | (9.98) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 |
|---|
| Total Revenue | 1.93 | 1.61 | 0.97 | 0.81 | 0.89 | 0.90 | 0.76 | 0.67 | 0.61 | 0.65 | 0.53 | 0.48 | 0.65 |
| Cost of Revenue | 0.27 | 0.22 | 0.14 | 0.14 | 0.15 | 0.14 | 0.12 | 0.10 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 |
| Gross Profit | 1.66 | 1.39 | 0.83 | 0.68 | 0.75 | 0.76 | 0.64 | 0.57 | 0.54 | 0.57 | 0.46 | 0.41 | 0.58 |
| Research & Development | 0.27 | 0.10 | 0.24 | 0.13 | 0.06 | 0.06 | 0.07 | 0.07 | 0.05 | 0.01 | -0.00 | 0.04 | 0.11 |
| Selling, General & Admin | 2.65 | 2.21 | 1.06 | 1.88 | 2.26 | 2.86 | 1.95 | 2.05 | 2.63 | 2.32 | 2.01 | 3.32 | 1.51 |
| Total Operating Expenses | 3.78 | 3.13 | 2.54 | 2.78 | 2.47 | 3.05 | 2.12 | 2.22 | 3.54 | 2.40 | 2.08 | 3.43 | 1.70 |
| Operating Income | (2.12) | (1.74) | (1.72) | (2.10) | (1.72) | (2.30) | (1.47) | (1.65) | (2.21) | (1.83) | (1.62) | (3.02) | (1.12) |
| Interest Expense | 0.02 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.06 | 0.08 | 0.03 | 0.02 | 0.10 | 0.19 |
| Net Income | (2.09) | (1.76) | (1.71) | (2.12) | (1.69) | (2.28) | (1.45) | (1.76) | (2.92) | (2.12) | (5.31) | (4.90) | (2.24) |
| Basic EPS | (0.19) | (0.18) | (0.16) | (0.24) | (0.22) | (0.33) | (0.23) | (0.25) | (0.42) | (0.32) | (0.85) | (1.35) | (1.21) |
| Diluted EPS | (0.19) | (0.18) | (0.16) | (0.24) | (0.22) | (0.33) | (0.23) | (0.25) | (0.42) | (0.32) | (0.85) | (1.35) | (1.21) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 |
|---|
| Operating Cash Flow | (1.03) | (1.23) | (1.93) | (1.43) | (1.47) | (1.60) | (1.76) | (1.39) | (1.62) | (1.33) | (2.63) | (2.82) | (1.25) |
| Capital Expenditures | 0.01 | -- | 0.01 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.00 | 0.01 |
| Free Cash Flow* | (1.04) | -- | (1.94) | (1.43) | (1.47) | (1.62) | (1.76) | (1.40) | (1.62) | (1.35) | (2.65) | (2.82) | (1.26) |
| Investing Cash Flow | (0.01) | -- | (0.11) | 0.00 | (0.01) | (0.02) | 0.00 | (0.03) | (0.02) | (0.01) | (0.02) | (0.04) | (0.01) |
| Financing Cash Flow | 2.28 | 3.34 | 2.63 | (0.18) | 5.46 | (0.07) | 5.19 | (0.11) | 3.31 | 1.35 | 1.96 | 3.57 | 1.06 |
* Derived from reported values
